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Abstract
Repeated psychostimulant exposure progressively increases their potency to stimulate motor
activity in rodents. This behavioral or locomotor sensitization is considered a model for some
aspects of drug addiction in humans, particularly drug craving during abstinence. However, the
role of increased motor behavior in drug reward remains incompletely understood. Intracranial
self-stimulation (ICSS) was measured concurrently with locomotor activity to determine if acute
intermittent cocaine administration had distinguishable effects on motor behavior and perception
of brain stimulation-reward (BSR) in the same mice. Sensitization is associated with changes in
neuronal activity and glutamatergic neurotransmission in brain reward circuitry. Expression of
AMPA receptor subunits (GluR1 and GluR2) and CRE binding protein (CREB) was measured in
the ventral tegmental area (VTA), dorsolateral striatum (STR) and nucleus accumbens (NAc)
before and after a sensitizing regimen of cocaine, with and without ICSS. Repeated cocaine
administration sensitized mice to its locomotor stimulating effects but not its ability to potentiate
BSR. ICSS increased GluR1 in the VTA but not NAc or STR, demonstrating selective changes in
protein expression with electrical stimulation of discrete brain structures. Repeated cocaine
reduced GluR1, GluR2 and CREB expression in the NAc, and reductions of GluR1 and GluR2 but
not CREB were further enhanced by ICSS. These data suggest that the effects of repeated cocaine
exposure on reward and motor processes are dissociable in mice, and that reduction of excitatory
neurotransmission in the NAc may predict altered motor function independently from changes in
reward perception.
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Although more than a century of clinical observations have described tolerance to the
euphoric effects of cocaine with compulsive use in humans, animal studies consistently
show sensitization to its behavioral effects with repeated exposure. Sensitization to the
locomotor-stimulating effects of psychostimulants has been suggested as a behavioral
mechanism that may model aspects of human drug addiction, particularly drug craving
(Robinson and Berridge, 1993). While some studies have differentiated stimulant effects on
reward from their effects on learning mechanisms (Chen et al., 2008), fewer have attempted
to examine cocaine effects on both operant and Pavlovian behaviors in the same animals,
and investigate cellular adaptations occurring in those animals, during the course of repeated
cocaine exposure.
Intracranial self-stimulation (ICSS) is an operant behavior in which animals perform a task
to deliver electrical stimulation directly to brain reward circuitry (Carlezon and Chartoff,
2007; Kenny, 2007; Kornetsky and Bain, 1992; Olds and Milner, 1954; Wise, 1998). Drugs
of abuse, regardless of pharmacological class, potentiate the rewarding value of brain
stimulation-reward, or BSR (Kornetsky and Bain, 1992; Kornetsky and Duvauchelle, 1994).
Unlike their effects on locomotor behavior, the effects of psychostimulants (Bauco and
Wise, 1997; Frank et al., 1988; Gilliss et al., 2002; Kenny et al., 2003; Wise and Munn,
1993) and opioids (Bauco et al., 1993; Esposito and Kornetsky, 1977) on BSR do not appear
to sensitize with repeated exposure.
Cocaine exposure alters synthesis and membrane trafficking of AMPA-sensitive glutamate
receptor (AMPAR) subunits in an anatomically specific manner. Increased AMPAR
function and GluR1 synthesis in dopaminergic neurons of the mesencephalic ventral
tegmental area (VTA) are well-characterized early responses to psychostimulants (Carlezon
and Nestler, 2002; Churchill et al., 1999; Fitzgerald et al., 1996; Saal et al., 2003; Ungless et
al., 2001; White et al., 1995; Zhang et al., 1997) but see (Lu et al., 2002). Repeated non-
contingent cocaine exposure and withdrawal increases AMPAR synthesis (Churchill et al.,
1999; Lu et al., 2003), surface expression (Boudreau and Wolf, 2005) and function (Pierce
et al., 1996) in nucleus accumbens (NAc) medium spiny neurons that reverses upon re-
exposure to cocaine (Kourrich et al., 2007; Thomas et al., 2001) due to receptor
internalization (Boudreau et al., 2007). The transcription factor CRE binding protein
(CREB) is a key regulator of cellular processes affecting neuronal excitability and synaptic
plasticity in response to drugs of abuse (Carlezon et al., 1998; Dong et al., 2006), and may
act in part by regulating expression of glutamate receptor subunits (Olson et al., 2005).
The goal of these experiments was to determine if measurement of locomotor activity and
BSR threshold in the same animal could distinguish the effects of repeated, intermittent
cocaine exposure on motor behavior and reward processes, respectively. In addition, to
determine if BSR leads to similar adaptive changes in neuronal activity we measured
expression of proteins involved in glutamatergic transmission (GluR1 and GluR2) and
regulation of cellular activity (CREB) in VTA, NAc and dorsolateral striatum (STR), three
brain regions implicated in both motor behavior and reward, after repeated ICSS with and
without concurrent repeated cocaine exposure.
2. MATERIALS AND METHODS
2.1 Animal Care and Handling
All experimental animal procedures were carried out according to the NIH Guide to the
Care and Use of Laboratory Animals and were approved by the Institutional Animal Care
and Use Committee at the University of North Carolina at Chapel Hill.
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2.2 Intracranial Self-Stimulation (ICSS)
Sixty-two male white Swiss-Webster mice (Taconic Labs) P50–P60 were anesthetized
(ketamine/xylazine 120/18 mg/kg i.p.; Sigma) and stereotaxically implanted with insulated
monopolar steel electrodes (0.28 mm diameter; Plastics One, Roanoke VA) to the right
median forebrain bundle in the lateral hypothalamus using coordinates from Paxinos and
Franklin (1996): bregma −2.0 mm (a/p), sagital +0.8 mm (m/l) and depth −4.5 mm (d/v). A
steel screw (electrical ground) and the electrode assembly were secured to the skull with
dental cement. After recovery mice were individually housed with food and water freely
available
Mice were divided into four experimental groups (A, B, C, and D). Groups A and B mice
were used for ICSS experiments while Groups C and D mice served as non-ICSS controls
(see below). One week after implantation, mice for intracranial self-stimulation (ICSS)
experiments (Groups A and B, Figure 1) were trained on a continuous (FR-1) schedule of
reinforcement for brain stimulation-reward (BSR) in a 16 × 14 × 13 cm operant chamber
with a wheel manipulandum and a house light (MedAssociates, St. Albans VT). Each
quarter-turn of the wheel earned a 500 msec train of unipolar cathodal square-wave current
at a frequency of 158 Hz (pulse width = 100 µsec) and activated the house light for 500
msec; subsequent responses during the 500 msec pulse train earned no additional
stimulation. Optimal stimulus intensity to sustain responding ≥40 responses/min was
determined for each animal (−90 to −220 µA) and was kept constant for all experiments.
Mice were then trained with a series of stimulus frequencies in descending order from 158
Hz to 19 Hz in 0.05 log10 increments (i.e., log10[112 Hz] = 2.05; log10[100 Hz] = 2.00, etc.).
At each frequency, five non-contingent priming stimuli were followed by 50 sec FR-1
access to BSR during which responses were measured. A 5 sec time-out period followed
each trial frequency during which responses earned no additional stimulation. Mice were
trained to complete four series of 15 trial frequencies (i.e., one hour daily). The frequency
range was adjusted for each mouse such that only the highest 4–6 frequencies sustained
responding. For each series of 15 frequencies, operant response rate for BSR was plotted
(i.e., the rate-frequency curve). BSR threshold (θ0) defined as the X-intercept of the least-
squares regression line through frequencies that sustained responding at 20, 30, 40, 50, and
60% of the maximal response rate in each series was calculated automatically by custom-
designed software. This determination of reward threshold is less sensitive to changes in
response rate than other calculations, e.g., EF50 (Miliaressis et al., 1986). Saline injections
began when BSR thresholds varied <±10% over three days. During training, sham-ICSS
(Group D) mice were placed in the operant chambers, attached to the stimulation apparatus
for one hour daily; and spinning the wheel had no consequences; while surgical control
(Group C) mice remained in their home cages and were handled daily.
On each test day, three rate-frequency curves were acquired before and four after injection
with saline vehicle or cocaine (Sigma). The first series (warm-up) was discarded; θ0 and
maximum rate from the second and third rate-frequency curves were averaged and used as
daily baselines for each animal. Cocaine (15 mg/kg as the free base) was administered in
normal saline by intraperitoneal injection. BSR thresholds and maximum response rates
were measured for four 15-minute series after cocaine or saline injections and expressed as
percent changes from baseline. Group D (novelty control) mice were placed in the ICSS
chambers for 45 minutes, injected with saline or cocaine, and returned to the chambers for
an additional hour, mimicking testing conditions for ICSS mice (Groups A and B). On
experimental day 7, ten ICSS mice (5 each from Groups A and B) and six non-ICSS surgical
control mice (Group C) were euthanized and brains were processed for protein
determinations. During cocaine abstinence (Days 19–32) Group A and B mice were tested
with ICSS and saline injections on alternate days and Group D mice were injected with
saline on the same schedule in the ICSS chambers.
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Locomotion was measured in transparent activity monitoring boxes (28 × 28 cm) separated
by opaque barriers in a darkened room. Beam breaks of a 16 × 16 infrared array were
quantified by commercial software (MedAssociates) and expressed as total distance traveled
(cm). All mice were placed in the locomotor boxes for 15 minutes (habituation), removed
and injected with either saline or cocaine (15 mg/kg i.p. as the free base), immediately
returned to the boxes, and monitored for 30 minutes. On experimental day 33 (see Figure 1)
locomotor activity was measured in all non-ICSS mice (Groups C and D) and in half of the
ICSS mice (Groups A and B) after cocaine challenge (15 mg/kg i.p.); cocaine effects on
BSR were measured in the other half of the Group A and B mice. On day 34, locomotor
activity was measured after cocaine in the half of Group A and B mice in which ICSS was
measured on day 33, and cocaine effects on BSR in the half that were challenged in the
locomotor apparatus on day 33. For each animal, locomotor sensitization to cocaine was
defined as a greater total distance traveled after cocaine on the last administration of the
initiation phase and on challenge than after the first administration in the locomotor
apparatus. Mice were euthanized and brains were processed for protein determinations 24
hours after completion of behavioral experiments. Only mice that demonstrated locomotor
sensitization were included in the analysis of cocaine and ICSS effects on protein
expression.
2.4 Protein Determinations
Mice were anesthetized with sodium pentobarbital (120 mg/kg) and brains were removed,
frozen in isopentane (−40°C), and serially sectioned on a cryostat to the rostral pole of the
NAc. A 1.0 mm slab was cut and bilateral tissue punches were taken from the NAc and STR
(18 and 17 gauge, respectively). Punches taken from structures contralateral and ipsilateral
to the ICSS electrode were stored separately for the first time point (day 7) and pooled for
the second time point (days 34/35; see Figure 1). Sectioning continued to the rostral
midbrain where a second 1.0 mm slab was cut and a single midline punch of the VTA (17
gauge) was taken. Tissues were sonicated in 1% SDS in TE (pH = 7.4) containing 1X
protease inhibitor cocktail (1 mM AEBSF, 0.08 µM aprotinin, 21 µM leupeptin, 36 µM
bestatin, 15 µM pepstatin A, and 14 µM E-64). Samples were centrifuged at 14,000 rpm ×
10 min and total protein concentrations were determined in supernatants (BCA Assay,
Pierce, Rockford, IL). 10.0 µg protein was run on a 10% SDS polyacrylamide gel, and
transferred to a polyvinylidene fluoride membrane (Immuno-Blot PVDF, 0.2 mm, Bio-Rad
Laboratories, Hercules CA). Blots were immersed in blocking buffer (5% non-fat dried milk
in 0.25 M Tris-HCL [pH = 7.6], 1.37 M NaCl, 0.1% Tween) for 60 min and probed with
primary antibody (GluR1: Chemicon, 1:850; GluR2: Chemicon, 1:1,000; CREB: Cell
Signaling, 1:500; β-Actin: Chemicon, 1:2,500) for 16 hours at 4°C. Blots were washed 4 × 5
min. each in blocking buffer and incubated with goat anti-rabbit (1:10,000 for GluR1;
1:5,000 for GluR2 and CREB) or horse anti-mouse (1:20,000 for β-Actin) horseradish
peroxidase-conjugated IgG (Vector Laboratories, Burlingame CA) for 1 hour at room
temperature, followed by 1 × 15 min and 4 × 5 min washes. Protein bands were detected by
chemiluminescence (Western Lightning, Perkin Elmer Life Sciences, Boston MA) and
exposed to autoradiographic film. Kaleidoscope-prestained standards (Bio-Rad) were used
for protein size determination. Anti-GluR1 and anti-GluR2 were detected at 108 kD; CREB
and β-Actin at 42 kD. Films were scanned for quantification and intensity of protein bands
were measured as optical density using ImageJ (v.1.32j; NIH, Bethesda MD).
2.5 Histology
During serial sectioning for tissue punches, coronal sections (50 µm) were collected through
the ICSS electrode tract by thaw-mounting onto subbed slides, stained with cresyl violet for
Riday et al. Page 4













Nissl, and electrode placements were confirmed under low-power (4X) light microscopy
(Figure 2).
2.6 Statistical Analysis
Statistical analyses were performed with SPSS 16.0 for Windows. ANOVA for repeated
measures was used to determine effects of ICSS training and serial θ0 determination on total
locomotion in mice sacrificed for protein determinations on day 7. For protein
measurements, band density of samples from ICSS tissues expressed as percentage of the
average optical density of all control bands in each blot were compared with Levene’s F test
for equality of variances followed by two-tailed t-tests for unmatched samples. Because of
the crossover design of the concurrent ICSS and locomotion experiments with cocaine
(Figure 1), ANOVA for repeated measures could not be applied to these data; three-way
ANOVA (experimental group × day of regimen × time after injection) was used to
determine differences between ICSS and control groups in locomotor behavior and between
ICSS groups (A vs. B) in θ0 and maximum operant response rate.
3. RESULTS
3.1 Effect of ICSS on Locomotor Behavior and Protein Expression
Analysis of locomotion during the saline habituation phase (experimental days 1–6 in Figure
1) showed significant main effects of experimental day (Saline 1–3; F (2, 13) = 16.48, P <
0.001); but no differences in locomotor behavior between mice that had received ICSS
training and concurrent BSR threshold (θ0) determinations and control mice (Figure 3).
Total distance traveled was significantly less in the 30 minutes after saline injection in all
mice (PRE vs. POST; F (1, 14) = 88.99, P < 0.001); and this habituation did not differ
between ICSS mice (Groups A and B; n = 10) and controls (Group C; n = 6). For this subset
of 16 mice that were sacrificed on experimental day 8 for protein determinations, there were
no significant interactions between experimental day (Saline 1–3), saline injection (PRE vs.
POST) or ICSS (vs. non-ICSS controls). Total electrical charge delivery, a function of both
stimulus amplitude (µA) and stimulus train frequency (Hz), is the most physiologically-
relevant measure of brain stimulation reward (Gallistel, 1978): baseline pre-injection BSR
thresholds expressed as charge (C, in Coulombs) at θ0 did not change significantly with
daily saline injections over six days in ICSS mice (Saline 1 = −5.50 ± 1.74 ×10−7 C; Saline
2 = −5.75 ± 1.82 ×10−7 C; Saline 3 = −6.17 ± 1.95 ×10−7 C).
Total tissue content of the AMPA-type glutamate receptor subunits GluR1 and GluR2 and
the transcription factor cAMP response element binding protein (CREB) were measured on
experimental day 7. Neither ICSS nor control mice demonstrated significant differences in
any protein levels between paired structures (nucleus accumbens, NAc; and dorsolateral
striatum, STR) ipsilateral and contralateral to the ICSS electrode placement: densities of
ipsilateral and contralateral samples were subsequently averaged. A significant increase in
total GluR1 expression (ICSS = 193 ± 35% of control, t = 2.60; df = 9; P < 0.05) but no
differences in total GluR2 or CREB levels were seen in the ventral tegmental area (VTA) of
mice that responded for BSR (Figure 4). There were no significant differences between
ICSS mice and controls in the STR (data not shown) or NAc for any proteins measured.
3.2 Effect of Repeated Acute Cocaine on Locomotion and ICSS
Repeated acute, intermittent cocaine administration (15 mg/kg i.p.) resulted in progressively
greater total locomotion in the large majority of mice tested: 20/20 control mice (Groups C
and D) and 17/24 ICSS mice (Groups A and B) sensitized to the locomotor-stimulating
effect of cocaine (Fisher’s Exact Test, ICSS vs. non-ICSS controls, P < 0.05). Initial
analysis of sensitized mice from all four experimental groups independently showed
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significant main effects of day of regimen (F (9,316) = 18.87, P < 0.001) but no main effect
of treatment group or interaction of day and treatment group on total locomotion after
cocaine. Sensitized control (Groups C and D) and ICSS mice (Groups A and B) were
subsequently pooled and analyzed: A significant effect of day of cocaine regimen (F (9,316)
= 20.46, P < 0.001) but not ICSS, and no interaction between day and ICSS, was found on
total locomotion after repeated cocaine (Figure 5). First locomotion measured after cocaine
administration (i.e., Cocaine 1 in Group A, Cocaine 2 in Group B) was significantly less
(4360 ± 701 cm) in the 17/24 ICSS mice that sensitized to cocaine than in the 7/24 ICSS
mice that did not demonstrate sensitization (9785 ± 1625 cm; t = −3.62; df = 22; P < 0.01;
Figure 5, inset). On the last day of cocaine initiation (Cocaine 5 for Group A; Cocaine 6 for
Groups B, C and D; see Figure 1), the 17 sensitized ICSS mice showed an average
locomotion of 334 ± 82% of their first day of cocaine in the locomotor apparatus (Cocaine 1
for Groups A, C and D; Cocaine 2 for Group B) compared to 417 ± 160% of Cocaine 1 in
controls (P = NS). On cocaine challenge, total locomotion was 298 ± 72% of first cocaine in
ICSS mice compared to 380 ± 129% of cocaine 1 in controls (P = NS). The seven ICSS
mice that did not sensitize to repeated cocaine uniformly showed interval decreases in total
locomotion between the first day of cocaine and both the last day of initiation (39 ± 7% of
first cocaine) and challenge (36 ± 11% of first cocaine).
Representative ICSS rate-frequency curves are shown in Figure 6A. Daily baseline pre-
injection BSR threshold expressed as charge delivery at θ0 did not change significantly over
34 days of the repeated cocaine regimen in ICSS mice (Figure 6B). In the overall three-way
ANOVA (group [A/B] × treatment day × time after injection) significant main effects of day
of regimen (F (14, 95) = 32.28, P < 0.001) and time after injection (F (3, 95) = 28.22, P <
0.001) on changes in θ0 to acute cocaine were seen (Figure 6C). No difference in θ0 changes
after saline or cocaine injection (15 mg/kg i.p.) was seen between Group A and Group B
mice, and no significant interactions between these variables were found. Post-hoc Tukey’s
tests showed that all cocaine days (Cocaine 1–6 and Challenge) differed significantly from
all saline days (Tukey’s HSD P < 0.001 for all comparisons), and that no saline days or
cocaine days differed from each other. A significant main effect of day of regimen (F (14, 95)
= 2.01, P < 0.05) on maximum operant response rate was also observed; however, post-hoc
Tukey’s tests did not support a significant effect of treatment day (Figure 6D). No
significant differences in maximum operant response rate after either saline or cocaine
injections were seen between Group A and Group B mice.
3.3 Effects of ICSS and Repeated Acute Cocaine on Protein Expression
After completion of behavioral experiments, total GluR1, GluR2, and CREB levels in the
VTA, NAc, and STR from sensitized mice were measured. There were no significant
differences between Groups A (n = 3) and B (n = 5) or between Groups C (n = 6) and D (n =
5) for any of the three proteins examined in any region; values for ICSS mice (Groups A and
B) and non-ICSS controls (Groups C and D) were subsequently averaged. Total GluR1
expression remained elevated in the VTA of ICSS mice but was not significantly greater
than non-ICSS controls (ICSS = 149 ± 60% of control; Figure 7, bottom left). No differences
in GluR2 or CREB levels were seen in the VTA. In the NAc both GluR1 (ICSS = 44 ± 4%
of control, t = −2.21; df = 17; P < 0.05) and GluR2 (ICSS = 53 ± 5% of control, t = −2.78;
df = 12; P < 0.02) but not CREB were significantly lower in ICSS mice than in non-ICSS
controls after cocaine (Figure 7, top). There were no significant differences in the STR
between ICSS mice and controls for any proteins measured (data not shown).
Optical densities (OD) for GluR1, GluR2 and CREB bands normalized to β-Actin OD in the
same lanes were compared between western blots of samples from non-ICSS control
subjects before (i.e., day 7; Group C, n = 6) and after cocaine challenge (Groups C and D, n
= 11). No significant differences were found between protein measurements from Group C
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and D mice after cocaine challenge, and values were subsequently averaged. In the VTA,
GluR2:β-Actin OD ratios were significantly greater in mice 24 hours after cocaine challenge
than in saline-treated mice on day 7 (t = −3.04; df = 15; P < 0.01), while non-significant
increases in GluR1:β-Actin and decreases in CREB:β-Actin were seen (Table 1, top). In the
NAc, GluR1:β-Actin (t = 2.10; df = 15; P < 0.05), GluR2:β-Actin (t = 3.75; df = 5; P <
0.02) and CREB:β-Actin (t = 4.83; df = 13; P < 0.01) were all significantly lower in samples
from mice after cocaine challenge (Table 1, bottom).
4. DISCUSSION
Since its development in initial studies of physiological and anatomical substrates of brain
reward over fifty years ago (Olds and Milner, 1954), intracranial self-stimulation (ICSS) has
been used to investigate mechanisms underlying the rewarding effects of drugs of abuse
(Kornetsky and Bain, 1992; Wise, 1996). One consistent observation in ICSS studies has
been the stability of brain stimulation-reward (BSR) to the reward-potentiating effects of
repeated psychostimulant administration, to which neither tolerance nor sensitization appear
to develop (Bauco and Wise, 1997; Frank et al., 1988; Gilliss et al., 2002; Kenny et al.,
2003; Wise and Munn, 1993). We found that repeated acute cocaine administration
sensitized mice to its effects on locomotion but not its reward-potentiating effect on BSR
measured in the same animals. Baseline reward thresholds did not change over the course of
locomotor sensitization; and increased total locomotion did not affect performance of the
operant task. We found no conditioned potentiation of BSR after repeated drug injection
(Kenny et al., 2003; Kokkinidis and Zacharko, 1980); that is, saline injections following
cocaine had no effect on ICSS performance or BSR thresholds consistent with a Pavlovian
conditioned response; nor did we observe elevations in baseline BSR thresholds during the
withdrawal phase of the experiment suggesting a generalized decrease in brain reward
function (Ahmed et al., 2002; Stoker and Markou, 2011). ICSS experiments in rats (Wise
and Munn, 1993) supported similar conclusions, that locomotor sensitization to
amphetamine was not associated with changes in its reward-potentiating effect; but because
of the long duration of action of amphetamine these measures were taken in series rather
than in parallel; and the locomotor sensitization observed was modest at the dose used.
However, when locomotor activity was measured concurrently with operant intravenous
cocaine self-administration in rats (Koeltzow and Vezina, 2005) no locomotor sensitization
was evident until after extinction and cocaine-primed reinstatement, after which both
operant responding and total locomotion were significantly increased. We conclude from
our data that the processes underlying enhanced motor behavior following repeated,
behaviorally non-contingent cocaine administration are dissociable from those mediating the
rewarding potency of cocaine in mice.
ICSS differs from drug self-administration in at least three important respects. First, satiety
does not develop for BSR. Unlike BSR, drug reward is followed by a consummatory
behavioral phase, which may include stimulated locomotor activity and during which
mechanisms of satiety engage to decrease motivational drive (Wise et al., 1995). Second, in
contrast to drug self-administration, where animals will work more to obtain a devalued
reward on a fixed-ratio of reinforcement (Hubner and Moreton, 1991; Yokel and Wise,
1975), devaluing BSR uniformly decreases operant responding to obtain it. Third, in ICSS
drug delivery is behaviorally non-contingent, i.e., investigator-administered; therefore the
rewarding effects of drugs are measured independent of the motivation of the animal to seek
or consume them.
Repeated non-contingent administration of cocaine or amphetamine robustly sensitizes rats
to their locomotor stimulating effects and ability to support conditioned place-preference
(Lett, 1989; Nocjar and Panksepp, 2002; Shippenberg and Heidbreder, 1995), but only
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modestly increases subsequent intravenous cocaine (Childs et al., 2006; Horger et al., 1990;
Schenk and Partridge, 2000) or amphetamine self-administration (Lorrain et al., 2000;
Mendrek et al., 1998; Piazza et al., 1990; Pierre and Vezina, 1997). Specifically, non-
contingent cocaine @@preexposure does not increase break points on progressive ratio
schedules of cocaine reinforcement (Childs et al., 2006), suggesting that the rewarding
potency of cocaine is unchanged (Richardson and Roberts, 1996). While cocaine self-
administration can result in locomotor sensitization in rats (Ben-Shahar et al., 2005;
Knackstedt and Kalivas, 2007; Phillips and Di Ciano, 1996) and mice (Zapata et al., 2003),
tolerance has also been observed; particularly after longer or more frequent access or with
escalating cocaine intake (Ahmed and Cador, 2006; Ben-Shahar et al., 2004; Lack et al.,
2008; Lecca et al., 2007). While concurrent measurements of BSR threshold and cocaine
self-administration in mice would be desirable to measure its rewarding potency over time,
and could be paired with activity measurements, such experiments are technically
prohibitive due to issues of long-term intravenous catheter patency. Our data suggest that
repeated non-contingent cocaine exposure increases behavioral activation but does not
change the absolute magnitude of cocaine reward in mice. This conclusion, which considers
drug-seeking behaviors independently from drug reward, is broadly consistent with recent
interpretations of the incentive sensitization theory of addiction forwarded by Robinson and
Berridge (2008).
The physiological and anatomical bases of ICSS have been extensively investigated (Wise,
2005), but few studies have examined if or how cellular adaptations occur with ICSS similar
to those that occur with cocaine and other drugs of abuse (Hyman and Nestler, 1996;
Kalivas and Volkow, 2005). This is relevant not only in the context of behavioral
reinforcement, but also to molecular changes that may occur with chronic electrical
stimulation of other discrete neural circuits, such as in therapeutic deep-brain stimulation for
the treatment of movement disorders or neuropsychiatric diseases (Henning et al., 2007;
Schulte et al., 2006). Carlezon et al. (2001) showed that ICSS decreased GluR1 expression
but did not change GluR2 in the rat VTA, a finding hypothesized to underlie the
insensitivity of BSR to drug sensitization (Carlezon and Nestler, 2002). In contrast, we
found that ICSS alone increased GluR1 expression in the mouse VTA, suggesting that VTA
neurons may initially adapt to BSR in manner similar to drug or other rewards. Notably, our
study and that of Carlezon et al. differed significantly in the duration and intensity of daily
ICSS, i.e. alternate-day rate-frequency BSR threshold determinations for 34 days versus
daily one-hour ad libitum access to suprathreshold BSR for nine consecutive days.
We found that a sensitizing cocaine regimen decreased both GluR1 and GluR2 expression in
the NAc, and extended those findings to show that this effect was greater in mice that self-
administered BSR, suggesting that the two reinforcers may be additive in their ability to
induce adaptive changes in glutamatergic sensitivity in the NAc. Interestingly, another study
(Levy et al., 2007) demonstrated GluR1 increases in VTA and decreases in NAc after a
similar cocaine sensitization regimen in rats, both of which were prevented by non-
contingent intracranial electrical stimulation of the lateral hypothalamus, which alone
resulted in measurable but non-significant GluR1 increases in VTA and decreases in NAc.
Manipulation of GluR1 and GluR2 in the NAc has opposite effects on BSR threshold; that
is, overexpression of GluR2 lowers and overexpression of GluR1 raises BSR threshold
(Todtenkopf et al., 2006). While we saw no changes in baseline BSR thresholds over the
course of the experiment, we did see reductions in both GluR1 and GluR2 in the NAc
consistent with sensitization, depression of excitatory neurotransmission and LTD after
repeated cocaine exposure (Bachtell et al., 2008; Thomas et al., 2001; Thomas et al., 2000),
which was further enhanced by ICSS. However, our results are not necessarily directly
comparable to others that have shown different molecular adaptations with either forced
drug abstinence (Lu et al., 2003) or extinction training (Sutton et al., 2003) after cocaine
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self-administration, because in our studies BSR, not cocaine, is the operant reinforcer; and
cocaine administration is behaviorally non-contingent.
Drugs of abuse induce adaptations in neural function in part by changing expression of
genes regulated by CREB activated through phosphorylation (pCREB) by MAPK/ERK and
cAMP/PKA signaling pathways in the NAc. Transgenic mice lacking normal CREB
demonstrate greater cocaine CPP (Walters and Blendy, 2001) and locomotor sensitization
(Sakai et al., 2002), and increased potentiation of BSR by cocaine (Dinieri et al., 2009).
Transiently decreasing CREB function in rats by viral overexpression of a dominant-
negative mutant protein (mCREB) in the NAc also increases cocaine CPP (Carlezon et al.,
1998), lowers baseline BSR threshold (Dinieri et al., 2009); and decreases excitability of
NAc medium spiny neurons (Dong et al., 2006), findings all consistent with increased brain
reward. We found that CREB levels in the VTA, striatum, and NAc were insensitive to
ICSS but were significantly decreased in the NAc after repeated cocaine exposure. It is
possible that this decrease may not be functionally significant given the relative levels of
constitutively-expressed CREB in the NAc versus the VTA. This is supported by the
observation that mutant mice (CREBαΔ) lacking 80–90% of normal CREB function still
respond to drug stimuli with elevations in pCREB and changes in pCREB-mediated gene
expression in the NAc but not the VTA, where CREB levels may be limiting (Walters et al.,
2003).
The ability to analyze changes in reward perception separately from changes in appetitive
behavior with animal models is an important step toward understanding the neurobiological
adaptations that occur with repeated exposure to drugs of abuse, and toward targeting
therapeutics specific to each process. While broadly consistent with incentive sensitization
theories of addiction, our findings do not preclude hedonic allostasis models (Koob and Le
Moal, 2008) in which reward perception would be expected to change with repeated drug
exposure and withdrawal, which may be the case for heroin (Kenny et al., 2006) or alcohol
(Schulteis and Liu, 2006; Schulteis et al., 1995), or for significantly higher chronic doses
(Stoker and Markou, 2011) or escalated self-administration of cocaine (Ahmed et al., 2002).
Further study of patterns of drug intake and their effects on brain reward using genetically-
engineered mouse models predictive of susceptibility will be particularly informative in this
regard. These findings also provide a foundation for mouse experiments in which individual
molecular functions are manipulated in a site-specific manner to dissect further the
distinction between the behaviorally-activating and rewarding properties of cocaine and
other drugs of abuse.
HIGHLIGHTS
► Locomotor activity but not brain stimulation-reward sensitizes to repeated
cocaine.
► Intracranial self-stimulation (ICSS) alone increases GluR1 expression in the
VTA.
► Repeated cocaine reduces GluR1, GluR2 and CREB in the nucleus
accumbens (NAc).
► GluR1 and GluR2, but not CREB, are further reduced in the NAc by cocaine
plus ICSS.
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Diagram of the experimental design for alternating measurement of intracranial self-
stimulation (ICSS) and locomotion in mice habituated to saline injections (days 1–6) and
given a repeated cocaine regimen (days 8–18) followed by withdrawal (days 19–32) and
cocaine challenge. For example, Group A mice received saline and ICSS was measured on
Day 1; received saline and locomotion was measured on Day 2; etc. ICSS mice (Groups A
and B) received saline and ICSS was measured every other day during cocaine withdrawal
(days 19–32). Cocaine challenge (15 mg/kg i.p.) was measured in half of Group A and
Group B mice with ICSS on day 33 and with locomotor activity on day 34; the other half
were challenged with locomotion measurement (day 33) then ICSS (day 34). Solid grey
lines (days 7, 9, etc.) indicate experimental days that mice remained in their home cages.
Days numbered in bold (days 8, 10, etc.) indicate experiments in which mice received
cocaine. Numbers in parentheses on day 7 indicate mice removed from the protocol for
protein determinations shown in Figure 3. See Materials and Methods for details.
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ICSS electrode placements in the medial forebrain bundle at the level of the lateral
hypothalamus. Electrode tip locations are plotted on templates from the standard mouse
stereotaxic atlas (Paxinos and Franklin, 1996) by manual inspection of Nissl-stained
sections. All electrodes were implanted on the right; control mice (white circles = non-/sham
ICSS; Groups C and D; n = 28) are shown on the left for clarity. Black circles = ICSS mice
(Groups A and B; n = 34); gray circles = non-sensitizing ICSS mice (n = 7). Locations of
tissue punches (dashed circles) are indicated in the nucleus accumbens (NAc; 18 gauge),
dorsolateral striatum (STR; 17 gauge) and ventral tegmental area (VTA; 17 gauge).
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Changes in locomotion over 30 minutes after i.p. saline injection (×3) on alternate days.
Values at each time point are plotted as mean distance traveled (in cm) ± S.E.M. White bars
= control mice (Group C; n = 6); black bars = ICSS mice (Groups A and B; n = 10; see
Figure 1). No differences between ICSS and control mice were found (see Results).
Tukey’s: * = P < 0.05 vs. pre-injection locomotion; † = P < 0.05 vs. Saline 1.
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ICSS increases total GluR1 in the VTA. Levels of AMPA receptor subunit proteins (GluR1;
GluR2) and the CRE binding protein (CREB) in homogenates of tissue punches taken from
the ventral tegmental area (VTA) and nucleus accumbens (NAc) on experimental day 7
(Figure 1; see Figure 2 for punch locations) are expressed as mean percentage change in
ICSS mice compared to non-ICSS control mice ± SEM. Western blots are shown from
representative samples. − / White bars = control (Group C; n = 6); + / black bars = ICSS
(Groups A and B; n = 10); mice are the same from which behavioral data are shown in
Figure 3. * = P < 0.05 vs. controls.
Riday et al. Page 18














ICSS does not alter locomotor sensitization to cocaine. Total locomotion over 30 minutes
after injection of saline or cocaine (15 mg/kg i.p.) in sensitized mice at each time point is
plotted as the mean distance traveled (in cm) ± SEM. White bars = Surgical and novelty
control mice (Groups C and D, respectively; n = 20); black bars = ICSS mice (Groups A and
B; n = 17). Letters indicate ICSS group tested on that day (see Figure 1). No differences
were seen between sensitized ICSS and sensitized control mice (see Results). Tukey’s: * =
P < 0.05 vs. Saline 1–3; † = P < 0.05 vs. Cocaine 1; ‡ = P < 0.05 vs. Cocaine 2. Inset: Total
locomotion over 30 minutes on Saline 3 and the first presentation of cocaine in the
locomotor apparatus (Cocaine 1 in Group A, Cocaine 2 in Group B, see Figure 1) to all
ICSS mice. Sensitized ICSS mice, n = 17; Non-Sensitized ICSS mice, n = 7. * = P < 0.05
vs. Sensitized.
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BSR potentiation does not sensitize to cocaine. (A) Representative ICSS rate-frequency
curves before (white circles) and after injection of saline (gray circles, dashed) or cocaine
(15 mg/kg i.p., black circles). In this mouse, baseline pre-injection BSR threshold (θ0) was
77.9 Hz, was unchanged (78.8 Hz) after saline injection; and was lowered by cocaine (15
mg/kg i.p.) to 41.0 Hz, or 53% of baseline θ0. (B) Baseline pre-injection BSR threshold
values expressed as mean charge delivery (in Coulombs) at θ0 ± SEM over the course of the
experiment. (C) Changes from baseline θ0 after each injection expressed as the mean
percentage of pre-injection θ0 ± SEM. Because the maximum effect of cocaine on BSR
occurs within the first 15 minutes after injection, only the first two post-injection epochs (30
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minutes total) are shown for clarity; see Results for details. (D) Pre-injection maximum
number of responses (right ordinate) and changes in maximum operant response rates after
each injection expressed as the mean percentage of pre-injection maximum response rates
(left ordinate) ± SEM. In (C and D) letters indicate group tested on that day (see Figure 1).
Black squares = pre-injection maximum operant response rate/minute (n = 17). Tukey’s: * =
P < 0.05 vs. all saline days; ‡ = P < 0.05 vs. Saline 1–3; † = P < 0.05 vs. first day of
cocaine withdrawal (Saline).
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Levels of AMPA receptor subunit proteins (GluR1; GluR2) and the CRE binding protein
(CREB) from homogenates of tissue punches taken from the ventral tegmental area (VTA)
and nucleus accumbens (NAc) 24 hours after completion of cocaine sensitization
experiments (see Figure 2 for punch locations). Western blots are shown from representative
samples; data are expressed as mean percentage change in ICSS mice compared to non-
ICSS control mice ± SEM. − / White bars = control (Groups C and D; n = 11); + / black
bars = ICSS (Groups A and B; n = 8); * = P < 0.05 vs. controls.
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TABLE 1
Comparison of GluR1, GluR2 and CREB levels in non-ICSS control mice before (Group C; n = 6) and after
(Groups C and D; n = 11) repeated intermittent cocaine administration, withdrawal and cocaine challenge (see
Figure 1).
Ventral Tegmental Area (VTA)
GluR1 GluR2 CREB
Before Cocaine (Day 7) 1.01 ± 0.20 0.70 ± 0.18 2.74 ± 0.64
After Cocaine (Day 34) 1.69 ± 0.40 1.84 ± 0.33* 1.43 ± 0.13
Nucleus Accumbens (NAc)
GluR1 GluR2 CREB
Before Cocaine (Day 7) 1.89 ± 0.46 2.09 ± 0.42 1.21 ± 0.05
After Cocaine (Day 34) 0.93 ± 0.23* 0.49 ± 0.08* 0.55 ± 0.12*
All values are expressed as mean ratio of optical density of bands to β-Actin in the same sample ± SEM.
*
t-test for unmatched samples (2-tailed) P ≤ 0.05 vs. Day 7.
See Results for details.
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